08 December 2022: Clinical Research
Predicting Chemotherapy Resistance in Gestational Trophoblastic Neoplasia: Ratio of Neutrophils, Lymphocytes, Monocytes, and Platelets
Gatot Nyarumenteng Adhipurnawan Winarno 1ABCDEF* , Ayu Insafi Mulyantari 1ABCDEF , Andi Kurniadi 1BD , Dodi Suardi 1BD , Zulvayanti Zulvayanti 1BD , Nurvita Trianasari 2CDOI: 10.12659/MSM.938499
Med Sci Monit 2022; 28:e938499
Table 2 Comparison of pre-chemotherapy NLR, LMR, PLR, and FIGO score with chemotherapy outcome in low-risk and high-risk GTN at Hasan Sadikin Hospital.
| Low risk | p value | High risk | p value | |||
|---|---|---|---|---|---|---|
| ChemoresistanceN=32 | ChemosensitiveN=34 | ChemoresistanceN=29 | ChemosensitiveN=34 | |||
| Mean±Std | 2020.74±825.065 | 2223.15±548.070 | 1589.30±820.385 | 2016.11±606.923 | ||
| Mean±Std | 532.55±297.451 | 500.53±127.463 | 690.66±520.987 | 545.38±213.719 | ||
| Mean±Std | 6203.68±2978.780 | 4554.92±1497.114 | 6641.28±3483.232 | 4297.55±2219.390 | ||
| Mean±Std | 327875.00±99682.31 | 331411.76±108341.52 | 355310.34±136636.92 | 311470.59±89163.53 | ||
| Mean±Std | 4.06±5.268 | 2.11±0.671 | 4.96±3.403 | 2.24±1.138 | ||
| Mean±Std | 4.30±2.222 | 4.64±1.469 | 3.03±1.576 | 4.16±1.649 | ||
| Mean±Std | 189.40±91.513 | 157.84±62.317 | 264.27±135.549 | 164.44±57.064 | ||
| Mean±Std | 4.84±1.322 | 4.03±1.325 | 8.21±1.521 | 8.44±1.727 | ||